RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
The new service delivers end-to-end support, managing every stage of an epigenomics project
The partnership initially will focus on cardiovascular and kidney diseases
The goal of the agreement is to advance cell and gene therapy accessibility by enabling scalable and efficient cell therapy manufacturing
Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target
Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering
The accelerated review covers WCK 5222 for multiple critical infections
The interim efficacy readout, involving around 170 participants with 15-month data, remains on track for the end of March 2026
The company plans to use the newly secured funding to expand the indications of its Grabody platform into high-unmet-need areas
Subscribe To Our Newsletter & Stay Updated
